Detalhe da pesquisa
1.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139274
2.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721561
3.
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
N Engl J Med
; 375(8): 717-29, 2016 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557300
4.
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
Lancet Oncol
; 19(3): 323-336, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29433963
5.
Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial.
Breast Cancer Res Treat
; 169(3): 497-505, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435853
6.
Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study.
Breast Cancer Res Treat
; 163(3): 507-515, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28324265
7.
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Mod Pathol
; 30(4): 509-518, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28084333
8.
Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials.
Lancet Oncol
; 17(7): e294-e304, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27396647
9.
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 6(11): e2342107, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966841
10.
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.
J Geriatr Oncol
; 13(5): 582-593, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101364
11.
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study.
Clin Cancer Res
; 27(20): 5482-5491, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301749
12.
Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial.
J Clin Oncol
; 38(11): 1186-1197, 2020 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083990
13.
CDK4/6 blockade in breast cancer: current experience and future perspectives.
Expert Opin Investig Drugs
; 26(12): 1357-1372, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29027483
14.
The past and future of breast cancer treatment-from the papyrus to individualised treatment approaches.
Ecancermedicalscience
; 11: 746, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28690677
15.
From bench to clinical trials the EORTC experience in biology-based clinical cancer research.
J Egypt Natl Canc Inst
; 29(4): 171-176, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122511
16.
Anti-angiogenic treatment in breast cancer: Facts, successes, failures and future perspectives.
Cancer Treat Rev
; 53: 98-110, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28088074
17.
Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer.
Eur J Cancer
; 72: 95-102, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28027521
18.
Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Eur J Cancer
; 82: 219-227, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292559
19.
Targeted adjuvant therapy in breast cancer.
Expert Rev Anticancer Ther
; 16(12): 1263-1275, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27741402
20.
The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeutics.
Ann Transl Med
; 4(14): 267, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27563654